Precision Medicine Center, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an 710061, China; The MED-X Institute, The First Affiliated Hospital of Xi'an Jiaotong University, Building 21, Western China Science and Technology Innovation Harbor, Xi'an 710000, China.
LC-BIO TECHNOLOGIES (HANGZHOU) CO., LTD., Hanghzhou 310000, China.
Blood Cells Mol Dis. 2022 Nov;97:102678. doi: 10.1016/j.bcmd.2022.102678. Epub 2022 Jun 2.
The T cell-mediated immune responses associated with asymptomatic infection (AS) of SARS-CoV-2 remain largely unknown. The diversity of T-cell receptor (TCR) repertoire is essential for generating effective immunity against viral infections in T cell response. Here, we performed the single-cell TCR sequencing of the PBMC samples from five AS subjects, 33 symptomatic COVID-19 patients and eleven healthy controls to investigate the size and the diversity of TCR repertoire. We subsequently analyzed the TCR repertoire diversity, the V and J gene segment deference, and the dominant combination of αβ VJ gene pairing among these three study groups. Notably, we revealed significant TCR preference in the AS group, including the skewed usage of TRAV1-2-J33-TRBV6-4-J2-2 and TRAV1-2-J33-TRBV6-1-J2-3. Our findings may shed new light on understanding the immunopathogenesis of COVID-19 and help identify optimal TCRs for development of novel therapeutic strategies against SARS-CoV-2 infection.
与 SARS-CoV-2 无症状感染(AS)相关的 T 细胞介导的免疫反应在很大程度上尚不清楚。T 细胞受体(TCR)库的多样性对于在 T 细胞反应中产生针对病毒感染的有效免疫至关重要。在这里,我们对来自五名 AS 受试者、33 名有症状的 COVID-19 患者和 11 名健康对照者的 PBMC 样本进行了单细胞 TCR 测序,以研究 TCR 库的大小和多样性。随后,我们分析了这三组研究对象中 TCR 库多样性、V 和 J 基因片段差异以及αβ VJ 基因配对的优势组合。值得注意的是,我们在 AS 组中发现了明显的 TCR 偏好,包括 TRAV1-2-J33-TRBV6-4-J2-2 和 TRAV1-2-J33-TRBV6-1-J2-3 的偏倚使用。我们的研究结果可能为理解 COVID-19 的免疫发病机制提供新的视角,并有助于确定针对 SARS-CoV-2 感染的新型治疗策略的最佳 TCR。